Lv1
40 积分 2025-10-22 加入
ERBB2-Activating Mutations and Co-Occurring Genomic Alterations Contribute to Disease Heterogeneity in Patients With ERBB2-Mutant Lung Cancer
2个月前
已完结
Occupational Exposure to Asbestos-Free Talc and Risk of Respiratory Cancers, Including Larynx, Lung, and Mesothelioma: A Systematic Review and Meta-Analysis
3个月前
已完结
Microplastic accumulation in the human lung: distinct signatures in lung cancer vs normal tissue
3个月前
已完结
Stress Promotes Lung Metastasis in Breast Cancer by Altering Neutrophil Differentiation
3个月前
已完结
TTF-1 Expression in Lung Adenocarcinoma: Clinicopathologic, Genomic, and Immunophenotypic Correlates and Outcomes to Immunotherapy-Based Treatments and KRASG12C Inhibitors
4个月前
已完结
Clinical Significance of MTAP Deletions and their Overlap with Concurrent Oncogenic Driver Alterations Including EGFR in Non-Small Cell Lung Cancer
4个月前
已完结
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
5个月前
已完结
Impact of KRAS Mutations and Co-Alterations on Outcomes in Stage III Nonsquamous NSCLC Treated With Chemoradiation and Immunotherapy
5个月前
已关闭
MTAP Loss Is Frequent in Oncogene-Driven NSCLC and May Confer Sensitivity to Combined PRMT5 Inhibitors and Targeted Therapies
5个月前
已完结
皖公网安备34019202002308
